Topical lincomycin gel in acne vulgaris: a multicentric placebo controlled study.

dc.contributor.authorSharma, A Den_US
dc.contributor.authorGupte, P Den_US
dc.contributor.authorSundaram, Men_US
dc.contributor.authorJanaki, V Ren_US
dc.contributor.authorRege, V Len_US
dc.contributor.authorBilimoria, F Een_US
dc.contributor.authorArora, Jen_US
dc.date.accessioned2009-05-28T08:33:51Z
dc.date.available2009-05-28T08:33:51Z
dc.date.issued2003-07-24en_US
dc.description.abstractINTRODUCTION: Acne vulgaris is commonly treated with topical antibacterials. We evaluated lincomycin gel, a new topical formulation for mild to moderate acne. MATERIAL AND METHODS: A multicentric, randomized, double blind, placebo controlled, clinical trial was conducted with lincomycin hydrochloride in 2% gel form in 200 patients with grade II and grade III acne. The severity of acne lesions was noted at baseline and after 4 weeks. RESULTS: About 70% cases in the study group showed a good to excellent response, which was significantly more as compared to 23% in the placebo group. The frequency and severity of adverse reactions in the two groups were similar. CONCLUSION: Lincomycin hydrochloride gel is an effective and safe treatment option for mild to moderate acne vulgaris.en_US
dc.description.affiliationWallace Pharmaceutical Ltd., Mumbai.en_US
dc.identifier.citationSharma AD, Gupte PD, Sundaram M, Janaki VR, Rege VL, Bilimoria FE, Arora J. Topical lincomycin gel in acne vulgaris: a multicentric placebo controlled study. Indian Journal of Dermatology, Venereology and Leprology. 2003 Jul-Aug; 69(4): 271-3en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/52794
dc.language.isoengen_US
dc.source.urihttps://www.ijdvl.comen_US
dc.titleTopical lincomycin gel in acne vulgaris: a multicentric placebo controlled study.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: